530 related articles for article (PubMed ID: 16209039)
1. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
Nikiforov YE
Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
[TBL] [Abstract][Full Text] [Related]
3. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
Albarel F; Conte-Devolx B; Oliver C
Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
[TBL] [Abstract][Full Text] [Related]
4. Pathology and genetics of thyroid carcinoma.
DeLellis RA
J Surg Oncol; 2006 Dec; 94(8):662-9. PubMed ID: 17131411
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK
Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
Maciel RM; Kimura ET; Cerutti JM
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):691-700. PubMed ID: 16444351
[TBL] [Abstract][Full Text] [Related]
7. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
[TBL] [Abstract][Full Text] [Related]
8. [Genetic factors predisposing to the development of papillary thyroid cancer].
Puzianowska-Kuźnicka M; Pietrzak M
Endokrynol Pol; 2005; 56(3):339-45. PubMed ID: 16350729
[TBL] [Abstract][Full Text] [Related]
9. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
10. Genetic and biological subgroups of low-stage follicular thyroid cancer.
French CA; Alexander EK; Cibas ES; Nose V; Laguette J; Faquin W; Garber J; Moore F; Fletcher JA; Larsen PR; Kroll TG
Am J Pathol; 2003 Apr; 162(4):1053-60. PubMed ID: 12651598
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
[TBL] [Abstract][Full Text] [Related]
12. [Oncogenes and thyroid tumors].
Lacroix L; Soria JC; Bidart JM; Schlumberger M
Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
[TBL] [Abstract][Full Text] [Related]
13. Signaling pathways in follicular cell-derived thyroid carcinomas (review).
Romitti M; Ceolin L; Siqueira DR; Ferreira CV; Wajner SM; Maia AL
Int J Oncol; 2013 Jan; 42(1):19-28. PubMed ID: 23128507
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathobiology of thyroid neoplasms.
Tallini G
Endocr Pathol; 2002; 13(4):271-88. PubMed ID: 12665646
[TBL] [Abstract][Full Text] [Related]
15. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
Kroll TG; Sarraf P; Pecciarini L; Chen CJ; Mueller E; Spiegelman BM; Fletcher JA
Science; 2000 Aug; 289(5483):1357-60. PubMed ID: 10958784
[TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas.
Rodrigues R; Roque L; Espadinha C; Pinto A; Domingues R; Dinis J; Catarino A; Pereira T; Leite V
Oncol Rep; 2007 Oct; 18(4):917-26. PubMed ID: 17786355
[TBL] [Abstract][Full Text] [Related]
17. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
[TBL] [Abstract][Full Text] [Related]
18. How molecular pathology is changing and will change the therapeutics of patients with follicular cell-derived thyroid cancer.
Couto JP; Prazeres H; Castro P; Lima J; Máximo V; Soares P; Sobrinho-Simões M
J Clin Pathol; 2009 May; 62(5):414-21. PubMed ID: 19147628
[TBL] [Abstract][Full Text] [Related]
19. Gene rearrangements in radiation-induced thyroid carcinogenesis.
Rabes HM
Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
[TBL] [Abstract][Full Text] [Related]
20. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
